Skip to main content

Table 1 Distribution of CVD risk factor status in stroke patients and their controls

From: Shorter GT repeat polymorphism in the heme oxygenase-1 gene promoter has protective effect on ischemic stroke in dyslipidemia patients

Variables

 

Stroke patients (n = 183)

Non-stroke patients (n = 164)

 

N (%)

N (%)

P

Gender

Male

114 (62.3)

87 (53.1)

0.0815

Diabetes

Yes§

64 (35.0)

19 (11.6)

<0.0001***

Hypertension

Yes&

151 (82.5)

90 (54.9)

<0.0001***

TC

≧240 mg/dL+

26 (14.2)

32 (19.5)

0.1861

Triglyceride

≧200 mg/dL+

44 (24.0)

38 (23.2)

0.8480

LDL-C

≧130 mg/dL+

52 (28.4)

66 (40.2)

0.0202*

HDL-C

<40/50 mg/dL in male/female

131 (71.6)

68 (41.5)

0.0001***

TC/HDL-C ratio

≧5+

66 (36.1)

58 (35.4)

0.8920

Smoker

Ever (current/past)

73 (39.9)

47 (28.7)

0.0804

BMI

≧27

23 (12.6)

40 (24.4)

0.0043**

Plaque score

≧3

83 (45.3)

43 (26.2)

0.0002***

Genotype

L: >26 GT repeats

138 (75.4)

114 (69.5)

0.4262

  1. § fasting blood glucose ≧126 mg/dL or on DM medication. &SBP ≧140 mmHg or DBP ≧90 mmHg or on anti-hypertension medication. + included those patients with related medication. TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; BMI: body mass index. P: the p value from chi-square test between stroke and non-stroke patients. Genotype; the length of GT repeats in HO-1 gene promoter. *: p < 0.05; **: p < 0.01; ***: p < 0.001
Back to article page

Journal of Biomedical Science

ISSN: 1423-0127